StonvexLoading…
StonvexCore line items from BLNK's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2025 2025-09-30 | Annual 2025 2025-06-30 | Annual 2025 2025-03-31 |
|---|---|---|---|---|
Revenue | $103.52M | $27.05M | $28.70M | $20.72M |
Operating Income | $-84.10M | $-451.00K | $-29.56M | $-21.38M |
Net Income | $-83.39M | $-332.00K | $-29.31M | $-21.01M |
EPS (Diluted) | $-0.76 | $0.00 | $-0.28 | $-0.21 |
Total Assets | $147.45M | Not available | Not available | Not available |
Total Liabilities | $82.96M | Not available | Not available | Not available |
Cash & Equivalents | $39.57M | Not available | Not available | Not available |
Free Cash Flow OCF − CapEx | $-40.56M | Not available | Not available | Not available |
Shares Outstanding | 142.13M | 109.11M | 102.90M | 102.47M |